The most useful question about Embody is not simply whether its advertised monthly price looks affordable. It is what, exactly, you would be buying before a clinician determines whether to prescribe. The site places that determination after checkout, while its subscription policy generally makes purchases nonrefundable, subject to a limited medical-disqualification exception. That sequence makes the checkout terms, clinical review process and refund calculation connected questions—not separate details to investigate after enrolling.
Embody, also called JoinEm at joinem.co, presents a GLP-1 weight-management program operated by Modern Metabolic Medicine, Inc., with medical treatment attributed to OpenLoop Health and fulfillment handled by independent pharmacies. This review examines public documentation consulted October 19, 2026, rather than independently verifying licenses, pharmacy quality or treatment results. The program documents several practical features, including optional coaching and multiple contact channels. However, its homepage prices differ materially from its terms, and its cancellation language uses two different clocks.
At a glance
- Who provides care
- Modern Metabolic Medicine operates Embody; the site attributes medical treatment to OpenLoop Health. JoinEm’s terms say the platform itself does not provide healthcare services.
- Advertised versus documented prices
- Homepage injection cards advertise $69/month for GLP-1 and $119/month for GLP-1/GIP. Separate Start and Flat pricing tables in the terms do not reconcile those offers.
- Clinical review follows checkout
- The site says an OpenLoop clinician determines prescription eligibility after checkout; the initial assessment does not establish a doctor-patient relationship with Embody.Sources: [8]
- Cancellation deadline
- The specific policy requires cancellation requests at least 72 hours before the next billing date, unlike homepage wording tied to the next shipment.
- Refund boundary
- Payments are generally final at purchase. Medical disqualification can trigger a refund of the unused current-term amount, with deductions for services considered used.Sources: [7]
What happens between the free assessment and a prescribing decision?
Embody advertises a two-minute initial assessment that requires no card to find out whether you qualify. That screening is not the same as prescription approval: its disclaimer says the assessment does not create a doctor-patient relationship with Embody. The site places an OpenLoop clinician’s eligibility determination after checkout and reserves prescribing decisions to those clinicians. Ask what the initial screening establishes, what remains undecided when payment is collected, and how a denial would be handled financially.
The intake described in the terms can collect past and current health conditions, medications, blood pressure, location and diagnostic tests when applicable. The FAQ describes review after intake and supporting documentation are submitted. If more information is needed, the provider may request a brief virtual appointment. Once treatment is approved, the prescription goes to a pharmacy for fulfillment. The documentation does not establish a clinical-review turnaround time or confirm that everyone receives a live appointment.
Basic access conditions are clearer than the full clinical criteria: users must be at least 18 and live in a U.S. state or territory where service is available. The terms say availability is limited to certain states and direct readers to support@joinem.co for the current list. Complete BMI criteria and systematic laboratory requirements are not established in the consulted material. For preparation, our starting questions guide helps separate screening, payment and clinical approval.
Which price would actually appear on your order?
The homepage advertises weekly GLP-1 injections at a “flat rate” of $69/month and GLP-1/GIP injections at $119/month. Those cards do not identify the active ingredient, required commitment or full plan total. A separate Pre-Black Friday banner advertises $200 in immediate savings and fast, free shipping without establishing the eligible plan, requirements or expiration. None of these statements explains how the homepage offers connect to the Start and Flat programs in the terms.
Start is explicitly introductory: its first-month prices rise in month two, as shown below. Flat instead describes fixed monthly pricing with optional commitment-based discounts. For semaglutide injection, Flat lists $199 monthly, $169/month for a three-month bundle, $159/month for six months and $149/month for twelve months. It also lists adjustments of +$50/month for semaglutide gum, +$100/month for tirzepatide injection and +$50/month for tirzepatide gum; the application of the gum adjustments is not fully explained.
Before authorizing payment, request the named program, exact product, first charge, later charges, renewal interval and full-term obligation in writing. The FAQ’s claim that price does not increase when dose changes within the same medication does not erase Start’s scheduled second-month increase. Our price questions checklist provides a way to compare the actual checkout offer rather than selecting whichever public price looks lowest.
| Product and presentation | First month | Month two onward |
|---|---|---|
| Semaglutide injection | $99 | $299/month |
| Semaglutide gum | $149 | $349/month |
| Tirzepatide injection | $149 | $399/month |
| Tirzepatide gum | $199 | $449/month |
What does the subscription include—and commit you to?
Embody says medication is included in the program cost. Its policy defines a single bundled price covering provider access, medication when clinically appropriate, laboratory services when applicable, online support and related services. That wording matters: it does not promise medication regardless of the prescribing decision or laboratory testing for every member. The price is not itemized by visit, shipment, service or month, and the policy says no component is separately refundable.
The terms authorize a charge at purchase followed by automatic recurring charges according to the selected plan until cancellation. The FAQ describes four-, twelve-, twenty-four- and fifty-two-week options shown at checkout, while the Flat table uses months. Four weeks should not be treated as a calendar month, and a package duration does not establish medication quantity. The consulted documentation does not settle whether bundles are collected entirely upfront or through another schedule, nor provide their final checkout totals.
Multi-month purchases nevertheless carry a stated full-term commitment in exchange for discounted bundled pricing. The refund policy excludes credits for unused months, unused services and undelivered or unshipped medication. Separately, the homepage promotes access without insurance-approval barriers; that does not establish insurance acceptance, reimbursement or coverage. HSA/FSA terms are also unconfirmed. Ask both what you owe at checkout and what obligation remains if you stop using the program before the purchased term ends.
What medicine and pharmacy would be assigned to you?
Embody’s documents discuss compounded semaglutide and tirzepatide injections, while its pricing terms also list gum presentations. The consulted material does not fully establish the gum formulations, current availability or presentation-specific safety information. A safety-page index includes Ozempic, Mounjaro and Rybelsus, but inclusion in that index is not confirmation that those branded products are offered or included at an advertised price. Request the exact prescription product and route before comparing offers.
The site names Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx as partners. It describes compounded prescriptions as prepared by state-licensed 503A pharmacies and attributes extensive quality testing to its partners. These are provider statements, not independent license or quality verification in this review. The pages do not identify which pharmacy would fulfill an individual order or provide batch-specific test results. Ask for the assigned pharmacy’s identity and a direct contact route.
FDA explains that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. That status alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Our medication questions guide can help organize a discussion about the proposed formulation and why it is being considered.
Who answers treatment questions after enrollment?
The division of responsibilities deserves attention. Modern Metabolic Medicine operates the platform, while the site attributes medical treatment to OpenLoop Health, described as a network of medical professional corporations and associations. JoinEm’s terms expressly say it does not provide healthcare services or hold a license to practice medicine. For patients, the practical question is which clinical practice and clinician will manage the prescription, document decisions and respond when a treatment concern needs medical rather than administrative attention.
The homepage advertises specialists available 24/7, unlimited appointments and messaging as often as needed. The contact page publishes support@joinem.co and (347) 269-4270, also describing around-the-clock availability. However, it specifically directs questions about personal treatment through the patient portal so they reach the clinician. These access claims do not establish a clinician response deadline, a required follow-up schedule or immediate clinical availability. Ask how urgent treatment messages are routed and what response expectations apply.
Optional care coaching is advertised as free and is not required to receive medication. Embody says coaches provide education, motivation and accountability but are not clinicians. That distinction prevents coaching access from being mistaken for medical follow-up. NIDDK describes follow-up as assessing treatment response and tolerability, not merely renewing payment. Before enrolling, ask who schedules clinical reviews, whether they occur proactively and how a member requests review between scheduled contacts.
What should you know before a shipment is sent?
Embody advertises free expedited home delivery but gives no numerical arrival window in the consulted material. The terms assign fulfillment and shipping to independent pharmacies and delivery carriers that Modern Metabolic Medicine does not own, operate or control. Clinical approval, pharmacy preparation, dispatch and arrival are therefore different steps. Ask when tracking becomes available, which party handles delays, how frequently shipments occur and what arrangements apply to temperature-sensitive deliveries.
For damaged items, the policy says a pharmacy may provide a replacement after receiving evidence of damage. Incorrect items are also to be replaced. In both cases, the policy identifies replacement—not a refund—as the remedy. Keeping packaging and documenting the problem may help establish what happened, but the pages do not define a complete reporting procedure or resolution timeline. Confirm the appropriate pharmacy and platform contacts before the first shipment rather than assuming one support team controls every step.
FDA specifically advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. This clinical guidance is separate from Embody’s commercial replacement policy. The public documentation does not establish its cold-chain procedures. A useful pre-shipment question is how the pharmacy wants temperature concerns reported and who will determine the next step, without asking a patient to judge product usability from advertising language.
Which cancellation deadline should you put on your calendar?
The homepage says cancellation before the next medication shipment avoids the upcoming charge, with cancellation deferred if that shipment has already been processed. The specific policy instead requires receipt of a cancellation request at least 72 hours before the next billing date. Requests inside that window lead to the current cycle’s nonrefundable charge and cancellation at the subsequent cycle. These are not interchangeable deadlines: a shipment date does not tell you when the billing cutoff occurs.
The policy allows cancellation through support@joinem.co, +1 (347) 269-4270 or the online account/patient portal. Ask for the next billing date, applicable cutoff and written confirmation of cancellation’s effective date. Cancellation should not be understood as a refund or release from an already purchased bundled term. Our renewal questions guide helps organize the dates, notice requirements and records worth retaining before another charge.
Payments are generally final at purchase even if intake is unfinished, a consultation is missed or a prescription is not filled or accepted. The medical-disqualification exception refunds only the unused current-term amount. Deductions can include clinical review, consultations, issued prescriptions, medication dispensed or shipped, and laboratory services ordered or performed. Those deduction amounts are not quantified publicly, so ask for an explanation of the calculation rather than assuming a denial produces a full refund.
What documentation helps you evaluate continuity and claims?
Embody welcomes people already taking GLP-1 medication and asks for proof of the current prescription for professional review. That is a documented transfer pathway, not a guarantee of an unchanged prescription or uninterrupted supply. Ask what records are needed, when review occurs and how the proposed plan is communicated. The privacy notice also permits requests to inspect or obtain medical and billing records, subject to limited exceptions; copies can carry a cost-based fee.
The site says its benefits claims refer to self-reported customer data from plans combining compounded GLP-1 medication and medical consultations. Such reports should not be presented as independently verified provider outcomes. The site also discloses that some materials may be AI-generated or enhanced and that people in advertisements may be actors or models. These disclosures make it particularly useful to request the underlying evidence rather than treating an advertisement as a clinical record.
This documentary review does not establish individual treatment suitability, pharmacy performance or expected weight loss. It also cannot confirm Spanish-language care, interpreter access, a complete state list or all terms: an intermediate portion of the consulted terms text was omitted. The useful next step is targeted confirmation of unresolved details, particularly the actual order price, assigned clinical and pharmacy teams, and refund consequences of a post-payment eligibility decision.
Questions & answers
Can I assume Embody’s $69 monthly injection offer applies to me?
No. The homepage advertises that rate but does not identify the active ingredient, qualifying commitment or complete plan total on the card. The terms list different Start and Flat prices. Request a written checkout summary explaining which offer applies, the exact medication presentation, what is collected initially and what later renewals cost.
Does the free assessment guarantee a prescription?
No. Embody says the assessment does not establish a doctor-patient relationship with it, and an OpenLoop clinician determines prescription eligibility after checkout. The general nonrefundability rule has a medical-disqualification exception, but that exception can involve deductions. Clarify the financial consequences of clinical ineligibility before paying, not just whether the screening is free.
Can I transfer to Embody from another GLP-1 service?
The site accepts transfer requests and asks for proof of your current prescription for provider review. It does not promise automatic continuation or a particular approval timeline. Ask what records are required, which clinician reviews them and how you will learn the decision. Do not interpret transfer acceptance as a guarantee of the same prescription.
Is Embody’s coaching the same as clinician access?
No. Coaching is described as optional, free and provided by nonclinicians for education, motivation and accountability. Treatment questions should go through the patient portal to reach the clinician. Although Embody advertises 24/7 support and unlimited appointments, its public material does not establish a specific clinician response time or mandatory follow-up interval.
Will canceling before shipment prevent another charge?
Do not rely on shipment timing alone. The homepage uses shipment-based language, but the specific policy requires the cancellation request at least 72 hours before the next billing date. Confirm that date and obtain cancellation confirmation. Stopping future renewal does not itself refund a current purchase or unused portions of a bundled commitment.
Which pharmacy will fill my Embody prescription?
The site lists Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx, but the consulted pages do not assign an individual patient to one. Ask for the dispensing pharmacy’s identity and contact information. Embody attributes fulfillment to independent third parties; listing a partner does not independently verify its licensing, testing or performance.
Our assessment
Embody documents a recognizable care pathway, named clinical and pharmacy relationships, conditional bundled services, optional coaching and several support channels. Those details give prospective patients concrete questions to pursue. The main obstacle to a clear enrollment decision is the combination of unreconciled prices, clinical eligibility review after checkout and broad nonrefundability with a limited exception. The shipment-versus-billing cancellation discrepancy adds another practical risk of misunderstanding. Before paying, obtain one written explanation covering the exact product, first and recurring charges, full-term commitment, medical-disqualification deductions and cancellation cutoff. The public record supports evaluating Embody as a GLP-1 program, but not treating its lowest advertised price, support claims or customer-reported benefits as a complete account of the purchase or likely outcome.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Embody (joinem.co; también denominado JoinEm) — pages/privacy practices ↗
- Embody (joinem.co; también denominado JoinEm) — pages/contact ↗
- Embody (joinem.co; también denominado JoinEm) — pages/glp1_medication_safety_information ↗
- Embody (joinem.co; también denominado JoinEm) — pages/terms conditions ↗
- Embody (joinem.co; también denominado JoinEm) — pages/refund policy ↗
- Embody (joinem.co; también denominado JoinEm) — official website ↗